Global Digital Therapeutics Market is valued at $2.2bn & is expected to revolutionize the Digital Health Industry - Innovative Business Models set to impact Behavioral Health, Diabetes Conditions & CNS
The global digital therapeutics market is valued at $ 2.2 billion (2020) and is set to gain significant momentum. The next phase of growth is likely to be driven by growing pharma-digital therapeutic alliances, growing focus of digital therapeutics companies on mental health, psychiatric conditions and cognitive impairments, gradually improving reimbursement scenario, favorable funding environment and strong pipeline of digital therapeutics products. Changing medical protocols, need to curtail costs, evolution and widespread adoption of technology specifically in the areas of artificial intelligence, deep learning and health monitoring using wearables is increasingly transforming healthcare and has paved the way for a new class of therapeutics known as digital therapeutics (DTx). Digital therapeutics are products (software programs) that deliver evidence-based therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease (Source: Digital Therapeu...